查看購物車
  • Simplified Chinese
  • English
南美洲和中美洲生物分析測試服務市場預測至 2030 年 - 區域分析 - 按服務分類；疾病適應症；和最終用戶
市場調查報告書
商品編碼
1463671

南美洲和中美洲生物分析測試服務市場預測至 2030 年 - 區域分析 - 按服務分類；疾病適應症；和最終用戶

South & Central America Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services ; Disease Indication ; and End User
出版日期: | 出版商: The Insight Partners | 英文 100 Pages | 訂單完成後即時交付

價格

2022年南美洲和中美洲生物分析測試服務市值為2.4243億美元，預計到2030年將達到4.9176億美元；預計 2022 年至 2030 年CAGR為 9.2%。

製藥業的不間斷成長推動了南美洲和中美洲生物分析測試服務市場

藥品及其他醫藥產品的研發、生產及銷售是醫藥工業的主要領域。隨著治療年齡相關疾病和慢性病的藥物需求不斷增加，全球藥品消費量不斷增加。根據世界衛生組織預測，從2020年到2050年，60歲或以上的老年人口預計將增加一倍，到2050年將達到約21億。疾病、癌症、高血壓、骨關節炎和糖尿病。因此，慢性病一直是製藥公司關注的主要領域。新藥開發是一個資源、成本和時間密集的過程，後期的臨床階段會導致巨大的成本。多家製藥公司選擇生物分析測試服務來進行藥物開發以及臨床和臨床前階段的檢測驗證。學名藥和品牌藥物化合物大多是小分子。學名藥製造商進行並提交生物分析測試結果，以克服專利到期的問題。因此，隨著製藥業的不斷發展，生物分析檢測服務提供者未來的服務需求可能會持續成長，這將為生物分析檢測服務市場帶來新的成長機會。

南美洲和中美洲生物分析測試服務市場概述

南美洲和中美洲的生物分析測試服務市場細分為巴西、阿根廷以及南美洲和中美洲的其他地區。該地區的市場成長主要歸功於全球製藥公司在該地區建立業務的持續努力，以及各國對疾病意識的增強和醫療保健支出的增加。

南美洲和中美洲生物分析測試服務市場收入及 2030 年預測（百萬美元）

南美洲和中美洲生物分析測試服務市場細分

南美洲和中美洲生物分析測試服務市場根據測試類型、疾病適應症、最終用戶和國家進行細分。

根據測試類型，南美洲和中美洲生物分析測試服務市場分為藥物動力學、生物標記、免疫原性、病毒學測試、基於細胞的測定等。 2022 年，基於細胞的檢測領域佔據最大的市場佔有率。

根據疾病指示，南美洲和中美洲生物分析測試服務市場分為心血管、神經系統疾病、代謝紊亂、呼吸系統疾病、自體免疫疾病、腫瘤、性健康、骨骼疾病等。 2022 年，腫瘤學領域佔據最大的市場。

根據最終用戶，南美洲和中美洲生物分析測試服務市場分為製藥和生物製藥公司、合約研究組織（CRO）、合約開發和製造組織（CDMO）等。 2022 年，製藥和生物製藥公司領域佔據最大的市場佔有率。

根據國家/地區，南美洲和中美洲生物分析測試服務市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，巴西在南美洲和中美洲生物分析測試服務市場佔有率中佔據主導地位。

SGS SA、康龍化成北京有限公司、Element Materials Technology Group Ltd、Charles River Laboratories International Inc、Eurofins Scientific SE、Labcorp Drug Development Inc、Syneos Health Inc、ICON Plc 和 Intertek Group Plc 是在南方營運的一些領先公司＆中美洲生物分析測試服務市場。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲生物分析測試服務市場格局

  • 概述
  • PEST分析
    • 南美洲和中美洲 PEST 分析

第 5 章：南美洲和中美洲生物分析測試服務市場 - 主要產業動態

  • 主要市場促進因素：
    • 藥廠增加研發活動外包
    • 對生物相似藥和生物製劑分析測試的高需求
  • 主要市場限制：
    • 與生物分析測試服務相關的高成本
  • 主要市場機會
    • 醫藥產業持續成長
  • 未來的趨勢
    • 針對新興罕見疾病的藥物發現和開發活動不斷增加
  • 影響分析：

第 6 章：生物分析測試服務市場 - 南美洲和中美洲市場分析

  • 生物分析測試服務市場收入，2022 - 2030

第 7 章：南美洲和中美洲生物分析測試服務市場 - 收入和 2030 年預測 - 按服務

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按服務分類）（%）
  • 藥物動力學
  • 生物標記
  • 免疫原性
  • 病毒學檢測
  • 基於細胞的檢測
  • 其他

第 8 章：南美洲和中美洲生物分析測試服務市場 - 收入和 2030 年預測 - 按疾病指示

  • 概述
  • 2022 年和 2030 年按疾病適應症分類的生物分析測試服務市場收入佔有率 (%)
  • 心血管
  • 神經系統疾病
  • 代謝紊亂
  • 腫瘤學
  • 性健康
  • 骨病
  • 其他

第 9 章：南美洲和中美洲生物分析測試服務市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年生物分析測試服務市場收入佔有率（按最終用戶分類）（%）
  • 製藥和生物製藥公司
  • 合約研究組織（CRO）
  • 合約開發與製造組織 (CDMO)
  • 其他

第 10 章：南美洲和中美洲生物分析測試服務市場 - 國家分析

  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地區

第 11 章：生物分析測試服務市場產業格局

  • 概述
  • 生物分析測試服務市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • SGS SA
  • Pharmaron Beijing Co Ltd
  • Element Materials Technology Group Ltd
  • Charles River Laboratories International Inc
  • Eurofins Scientific SE
  • Labcorp Drug Development Inc
  • Syneos Health Inc
  • ICON Plc
  • Intertek Group Plc

第 13 章：附錄

Product Code: BMIRE00029566

The South & Central America bioanalytical testing services market was valued at US$ 242.43 million in 2022 and is expected to reach US$ 491.76 million by 2030; it is estimated to grow at a CAGR of 9.2% from 2022 to 2030.

Uninterrupted Growth of Pharmaceuticals Industry Fuel the South & Central America Bioanalytical Testing Services Market

The research & development, production, and distribution of medicinal drugs and other pharmaceutical products are the major areas of the pharmaceutical industry. Global pharmaceutical consumption is rising with the increasing need for drugs to treat age-related diseases and chronic diseases. According to the WHO, the elderly population aged 60 or above is projected to double from 2020 to 2050, reaching ~2.1 billion by 2050. A rise in the geriatric population would contribute to a surge in incidences of chronic diseases, such as cardiovascular diseases, cancer, hypertension, osteoarthritis, and diabetes mellitus. Thus, chronic diseases have been a major area of focus for pharmaceutical companies. New drug development is a resource-, cost-, and time-intensive process, where later clinical stages result in significant costs. Several pharmaceutical companies are opting for bioanalytical testing services for drug development and validation of assays in both clinical and preclinical stages. Generics and branded drug compounds are mostly small molecules. Generics manufacturers conduct and submit bioanalytical testing results to overcome the issue of patent expiration. Thus, with the uninterrupted proliferation of the pharmaceutical industry, bioanalytical testing service providers are likely to experience a continuous rise in demand for their services in the future, which would lead to new growth opportunity in the bioanalytical testing services market.

South & Central America Bioanalytical Testing Services Market Overview

The bioanalytical testing services market in South & Central America is sub segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed to the ongoing efforts of global pharmaceutical companies to establish their presence in the region, along with the increasing awareness about diseases and rising healthcare expenditure by countries.

South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bioanalytical Testing Services Market Segmentation

The South & Central America bioanalytical testing services market is segmented based on test type, disease indication, end user, and country.

Based on test type, the South & Central America bioanalytical testing services market is segmented into pharmacokinetics, biomarkers, immunogenicity, virology testing, cell-based assays, and others. The cell-based assays segment held the largest market share in 2022.

Based on disease indication, the South & Central America bioanalytical testing services market is segmented into cardiovascular, neurological disorders, metabolic disorders, respiratory diseases, autoimmune disorder, oncology, sexual health, bone disease, and others. The oncology segment held the largest market share in 2022.

Based on end user, the South & Central America bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract research organization (CRO), contract development and manufacturing organization (CDMO), and others. The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2022.

Based on country, the South & Central America bioanalytical testing services market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bioanalytical testing services market share in 2022.

SGS SA, Pharmaron Beijing Co Ltd, Element Materials Technology Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Labcorp Drug Development Inc, Syneos Health Inc, ICON Plc, and Intertek Group Plc are some of the leading companies operating in the South & Central America bioanalytical testing services market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Bioanalytical Testing Services Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
    • 5.1.2 High Demand for Analytical Testing of Biosimilars and Biologics
  • 5.2 Key Market Restraints:
    • 5.2.1 High Cost Associated to Bioanalytical Testing Services
  • 5.3 Key Market Opportunities
    • 5.3.1 Uninterrupted Growth of Pharmaceuticals Industry
  • 5.4 Future Trends
    • 5.4.1 Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
  • 5.5 Impact Analysis:

6. Bioanalytical Testing Services Market - South & Central America Market Analysis

  • 6.1 Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • 7.3 Pharmacokinetics
    • 7.3.1 Overview
    • 7.3.2 Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Biomarkers
    • 7.4.1 Overview
    • 7.4.2 Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunogenicity
    • 7.5.1 Overview
    • 7.5.2 Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Virology Testing
    • 7.6.1 Overview
    • 7.6.2 Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 In-Vitro Virology Testing
        • 7.6.2.1.1 Overview
      • 7.6.2.2 In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.6.3 In-Vivo Virology Testing
      • 7.6.3.1 Overview
      • 7.6.3.2 In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Cell-Based Assays
    • 7.7.1 Overview
    • 7.7.2 Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by Disease Indication

  • 8.1 Overview
  • 8.2 Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • 8.3 Cardiovascular
    • 8.3.1 Overview
    • 8.3.2 Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Neurological Diseases
    • 8.4.1 Overview
    • 8.4.2 Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Metabolic Disorders
    • 8.5.1 Overview
    • 8.5.2 Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Oncology
    • 8.6.1 Overview
    • 8.6.2 Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Sexual Health
    • 8.7.1 Overview
    • 8.7.2 Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Bone Disease
    • 8.8.1 Overview
    • 8.8.2 Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Others
    • 8.9.1 Overview
    • 8.9.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioanalytical Testing Services Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biopharmaceutical Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organization (CRO)
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Development and Manufacturing Organization (CDMO)
    • 9.5.1 Overview
    • 9.5.2 Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioanalytical Testing Services Market - Country Analysis

  • 10.1 South & Central America Bioanalytical Testing Services Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 South & Central America Bioanalytical Testing Services Market by Country
      • 10.1.1.2 Brazil
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Brazil Bioanalytical Testing Services Market, by Services
        • 10.1.1.2.3.1 Brazil Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.2.4 Brazil Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.2.5 Brazil Bioanalytical Testing Services Market, by End User
      • 10.1.1.3 Argentina
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Argentina Bioanalytical Testing Services Market, by Services
        • 10.1.1.3.3.1 Argentina Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.3.4 Argentina Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.3.5 Argentina Bioanalytical Testing Services Market, by End User
      • 10.1.1.4 Rest of South & Central America
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Rest of South & Central America Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Rest of South & Central America Bioanalytical Testing Services Market, by Services
        • 10.1.1.4.3.1 Rest of South & Central America Bioanalytical Testing Services Market, by Virology Testing
        • 10.1.1.4.4 Rest of South & Central America Bioanalytical Testing Services Market, by Disease Indication
        • 10.1.1.4.5 Rest of South & Central America Bioanalytical Testing Services Market, by End User

11. Bioanalytical Testing Services Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioanalytical Testing Services Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 SGS SA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pharmaron Beijing Co Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Element Materials Technology Group Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Charles River Laboratories International Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Eurofins Scientific SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Labcorp Drug Development Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Syneos Health Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ICON Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Intertek Group Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Bioanalytical Testing Services Market Segmentation
  • Table 2. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Services
  • Table 3. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 4. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 5. Brazil Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 6. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 7. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 8. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 9. Argentina Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Services
  • Table 11. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Virology Testing
  • Table 12. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - Disease Indication
  • Table 13. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 15. Recent Organic Growth Strategies in the Bioanalytical Testing Services Market
  • Table 16. Glossary of Terms, South & Central America Bioanalytical Testing Services Market

List Of Figures

  • Figure 1. South & Central America Bioanalytical Testing Services Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Bioanalytical Testing Services Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Bioanalytical Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Bioanalytical Testing Services Market Revenue Share, by Services 2022 & 2030 (%)
  • Figure 7. Pharmacokinetics: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Biomarkers: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Immunogenicity: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. In-Vitro Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. In-Vivo Virology Testing: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cell-Based Assays: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Bioanalytical Testing Services Market Revenue Share, by Disease Indication 2022 & 2030 (%)
  • Figure 16. Cardiovascular: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Neurological Diseases: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Metabolic Disorders: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Oncology: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sexual Health: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Bone Disease: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. South & Central America Bioanalytical Testing Services Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 24. Pharmaceutical and Biopharmaceutical Companies: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Contract Research Organization (CRO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Contract Development and Manufacturing Organization (CDMO): Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Others: Bioanalytical Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. South & Central America Bioanalytical Testing Services Market, By Country, 2022 ($Mn)
  • Figure 29. South & Central America Bioanalytical Testing Services Market, By Key Countries, 2022 And 2030 (%)
  • Figure 30. Brazil Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Argentina Bioanalytical Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Rest of South & Central America Bioanalytical Testing Services Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 33. Growth Strategies in the Bioanalytical Testing Services Market